Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada

By Grima Daniel T.  

PharmacoEconomics, Vol. 25, Iss. 3, 2007-01 ,pp. : 253-266

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus

By Ward Alexandra   O’Brien Judith A   Salas Maribel  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. : 601-608

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus

By Frederick B. Dong  

PharmacoEconomics, Vol. 22, Iss. 15, 2004-01 ,pp. : 1015-1027

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany: A Cardiff Diabetes Model Analysis

By Erhardt Wilma  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 189-202

Adis International

Access to resources Recommend Favorite

Hospitalisation, complications, raise treatment cost of type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite